Advertisement
Advertisement
CLRB
Cellectar Biosciences INC NEW
3.10
USDSponsored
-0.20
-6.06%
May 08, 15:58 UTC -4
Closed
After-Market
3.01
-0.09
-2.90%
CLRB Earnings Reports
Positive Surprise Ratio
CLRB beat 20 of 39 last estimates.
51%
Next Report
Tomorrow
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$2.46
Implied change from Q4 25 (Revenue/ EPS)
--
/+90.70%
Implied change from Q1 25 (Revenue/ EPS)
--
/-41.43%
Cellectar Biosciences INC NEW earnings per share and revenue
On Mar 04, 2026, CLRB reported earnings of -1.29 USD per share (EPS) for Q4 25, beating the estimate of -2.33 USD, resulting in a 44.85% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.21% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -2.46 USD, with revenue projected to reach -- USD, implying an increase of 90.70% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
Myomo Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+21.81%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
FAQ
What were Cellectar Biosciences INC NEW's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Cellectar Biosciences INC NEW reported EPS of -$1.29, beating estimates by 44.85%, and revenue of $0.00, 0% as expectations.
How did the market react to Cellectar Biosciences INC NEW's Q4 2025 earnings?
The stock price moved up 8.21%, changed from $2.68 before the earnings release to $2.90 the day after.
When is Cellectar Biosciences INC NEW expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Cellectar Biosciences INC NEW's next earnings report?
Based on 5
analysts, Cellectar Biosciences INC NEW is expected to report EPS of -$2.46 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement